Effect of Rifampicin on the Pharmacokinetics of HRS-1167 in Healthy Subjects

Clinical trial NCT06198556 · COMPLETED

Trial details

NCT number: NCT06198556
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2024-01-14
Primary completion: 2024-02-05
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.